The average length of stay for malignant neoplasm of the trachea, bronchus, and lung in France in 2024 is forecasted at 8.9 days, showing a slight decline to 8.6 days by 2028. Compared to 2023, there is a noticeable reduction indicating improvements in hospital efficiency or treatment advancements. From 2024 to 2028, the year-on-year decrease is subtle, averaging a consistent reduction trend. The 5-year compound annual growth rate (CAGR) suggests a mild annual decrease, reflecting ongoing enhancements in patient care and hospital processes.
Future trends to watch include the impact of new medical technologies and treatment methodologies that aim to further shorten hospital stays, enhancing recovery processes, and outpatient care capabilities. Additionally, policy changes and healthcare funding variations could influence these projections.
